231 related articles for article (PubMed ID: 31460969)
1. Which patients should receive the herpes zoster vaccine?
Short MD; Fergus C
JAAPA; 2019 Sep; 32(9):18-20. PubMed ID: 31460969
[TBL] [Abstract][Full Text] [Related]
2. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
Anderson TC; Masters NB; Guo A; Shepersky L; Leidner AJ; Lee GM; Kotton CN; Dooling KL
MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):80-84. PubMed ID: 35051134
[TBL] [Abstract][Full Text] [Related]
3. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines.
Dooling KL; Guo A; Patel M; Lee GM; Moore K; Belongia EA; Harpaz R
MMWR Morb Mortal Wkly Rep; 2018 Jan; 67(3):103-108. PubMed ID: 29370152
[TBL] [Abstract][Full Text] [Related]
4. Safety Profile of the Adjuvanted Recombinant Zoster Vaccine in Immunocompromised Populations: An Overview of Six Trials.
López-Fauqued M; Co-van der Mee M; Bastidas A; Beukelaers P; Dagnew AF; Fernandez Garcia JJ; Schuind A; Tavares-da-Silva F
Drug Saf; 2021 Jul; 44(7):811-823. PubMed ID: 34115324
[TBL] [Abstract][Full Text] [Related]
5. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
Lecrenier N; Beukelaers P; Colindres R; Curran D; De Kesel C; De Saegher JP; Didierlaurent AM; Ledent EY; Mols JF; Mrkvan T; Normand-Bayle M; Oostvogels L; Da Silva FT; Vassilev V; Vinals C; Brecx A
Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651
[TBL] [Abstract][Full Text] [Related]
6. A practitioner's guide to the recombinant zoster vaccine: review of national vaccination recommendations.
Parikh R; Widenmaier R; Lecrenier N
Expert Rev Vaccines; 2021 Sep; 20(9):1065-1075. PubMed ID: 34311643
[TBL] [Abstract][Full Text] [Related]
7. Recombinant Zoster Vaccine (Shingrix) to Prevent Herpes Zoster.
Sly JR; Harris AL
Nurs Womens Health; 2018 Oct; 22(5):417-422. PubMed ID: 30145235
[TBL] [Abstract][Full Text] [Related]
8. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
James SF; Chahine EB; Sucher AJ; Hanna C
Ann Pharmacother; 2018 Jul; 52(7):673-680. PubMed ID: 29457489
[TBL] [Abstract][Full Text] [Related]
9. Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice.
Stadtmauer EA; Sullivan KM; El Idrissi M; Salaun B; Alonso Alonso A; Andreadis C; Anttila VJ; Bloor AJ; Broady R; Cellini C; Cuneo A; Dagnew AF; Di Paolo E; Eom H; González-Rodríguez AP; Grigg A; Guenther A; Heineman TC; Jarque I; Kwak JY; Lucchesi A; Oostvogels L; Polo Zarzuela M; Schuind AE; Shea TC; Sinisalo UM; Vural F; Yáñez San Segundo L; Zachée P; Bastidas A
Hum Vaccin Immunother; 2021 Nov; 17(11):4144-4154. PubMed ID: 34406911
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B
Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live.
Curran D; Patterson BJ; Van Oorschot D; Buck PO; Carrico J; Hicks KA; Lee B; Yawn BP
Hum Vaccin Immunother; 2019; 15(4):765-771. PubMed ID: 30625011
[TBL] [Abstract][Full Text] [Related]
12. Preventing herpes zoster through vaccination: New developments.
Le P; Sabella C; Rothberg MB
Cleve Clin J Med; 2017 May; 84(5):359-366. PubMed ID: 28530894
[TBL] [Abstract][Full Text] [Related]
13. Update on the advisory committee on immunization practices' recommendations for use of herpes zoster vaccine.
Weaver BA;
J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S31-3. PubMed ID: 22086893
[TBL] [Abstract][Full Text] [Related]
14. A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations.
Prosser LA; Harpaz R; Rose AM; Gebremariam A; Guo A; Ortega-Sanchez IR; Zhou F; Dooling K
Ann Intern Med; 2019 Mar; 170(6):380-388. PubMed ID: 30776797
[TBL] [Abstract][Full Text] [Related]
15. Shingles vaccine.
Willison CB; Morrison LK; Mendoza N; Tyring SK
Expert Opin Biol Ther; 2010 Apr; 10(4):631-8. PubMed ID: 20113211
[TBL] [Abstract][Full Text] [Related]
16. Projected risks and health benefits of vaccination against herpes zoster and related complications in US adults.
Janusz CB; Anderson TC; Leidner AJ; Lee GM; Dooling K; Prosser LA
Hum Vaccin Immunother; 2022 Nov; 18(5):2060668. PubMed ID: 35476029
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster subunit vaccine for the prevention of herpes zoster.
Symoniak MR; Farrokh P; Gandhi MA; Slish JC
Am J Health Syst Pharm; 2018 Jun; 75(12):861-869. PubMed ID: 29880523
[TBL] [Abstract][Full Text] [Related]
18. The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis.
McGirr A; Widenmaier R; Curran D; Espié E; Mrkvan T; Oostvogels L; Simone B; McElhaney JE; Burnett H; Haeussler K; Thano A; Wang X; Newson RS
Vaccine; 2019 May; 37(22):2896-2909. PubMed ID: 30982636
[TBL] [Abstract][Full Text] [Related]
19. Herpes Zoster Vaccination: Controversies and Common Clinical Questions.
Van Epps P; Schmader KE; Canaday DH
Gerontology; 2016; 62(2):150-4. PubMed ID: 26184711
[TBL] [Abstract][Full Text] [Related]
20. Vaccination to prevent herpes zoster in older adults.
Gnann JW
J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
